PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
73.47%
Positive revenue growth while RUN is negative. John Neff might see a notable competitive edge here.
212.90%
Positive gross profit growth while RUN is negative. John Neff would see a clear operational edge over the competitor.
37.68%
Positive EBIT growth while RUN is negative. John Neff might see a substantial edge in operational management.
86.36%
Positive operating income growth while RUN is negative. John Neff might view this as a competitive edge in operations.
42.07%
Positive net income growth while RUN is negative. John Neff might see a big relative performance advantage.
43.14%
Positive EPS growth while RUN is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
43.14%
Positive diluted EPS growth while RUN is negative. John Neff might view this as a strong relative advantage in controlling dilution.
0.09%
Share reduction more than 1.5x RUN's 0.72%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
0.09%
Diluted share reduction more than 1.5x RUN's 0.31%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
No Data
No Data available this quarter, please select a different quarter.
57.23%
Positive OCF growth while RUN is negative. John Neff would see this as a clear operational advantage vs. the competitor.
45.43%
Positive FCF growth while RUN is negative. John Neff would see a strong competitive edge in net cash generation.
456.78%
10Y revenue/share CAGR above 1.5x RUN's 54.19%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
-26.49%
Negative 5Y CAGR while RUN stands at 54.19%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-2.58%
Negative 3Y CAGR while RUN stands at 54.19%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-1063.10%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-523.38%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-490.23%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
-311.40%
Negative 10Y net income/share CAGR while RUN is at 185.62%. Joel Greenblatt sees a major red flag in long-term profit erosion.
92.23%
Below 50% of RUN's 185.62%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
-132.84%
Negative 3Y CAGR while RUN is 185.62%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
33.48%
Equity/share CAGR of 33.48% while RUN is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
-22.74%
Negative 5Y equity/share growth while RUN is at 0.00%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
3.74%
Equity/share CAGR of 3.74% while RUN is zero. Bruce Berkowitz sees if minor gains can snowball into a bigger lead soon.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
10.80%
Our AR growth while RUN is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
-4.45%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
-2.01%
Negative asset growth while RUN invests at 6.99%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-1.03%
We have a declining book value while RUN shows 10.86%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
2.98%
Debt shrinking faster vs. RUN's 6.29%. David Dodd sees a safer balance sheet if it doesn't impair future growth.
-10.37%
Our R&D shrinks while RUN invests at 3.58%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-5.45%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.